» Articles » PMID: 24684787

Brain Lipidomes of Subcortical Ischemic Vascular Dementia and Mixed Dementia

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 2014 Apr 2
PMID 24684787
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Despite its importance as the leading cause of vascular dementia, the primary pathogenic mechanisms in subcortical ischemic vascular dementia (SIVD) have remained elusive. Because of the lack of approved therapeutic agents for SIVD, there is a pressing need to identify novel therapeutic targets. Comparative lipidomic analyses of SIVD and mixed dementia (i.e., SIVD and Alzheimer's disease, MixD) may also confer new insights pertaining to the possible interaction between neurodegenerative and vascular mechanisms in the pathogenesis of dementia. Liquid chromatography coupled to mass spectrometry was used to comprehensively analyze the lipidomes of white and gray matter from the temporal cortex of nondemented controls, SIVD, and MixD subjects. Detailed molecular profiles highlighted the pathologic relevance of gray matter sphingolipid fatty acyl chain heterogeneity in dementia. In addition, the levels of sulfatides and lysobisphosphatidic acids were progressively increased in the temporal cortex gray matter from control to SIVD to MixD. White matter phospholipid profiles indicated possible adaptive mechanisms (i.e., increased unsaturation) to chronic ischemia in SIVD and elevated membrane degradation in MixD.

Citing Articles

Dietary Supplementation with Naringin Improves Systemic Metabolic Status and Alleviates Oxidative Stress in Transition Cows via Modulating Adipose Tissue Function: A Lipid Perspective.

Li L, Bai S, Zhao H, Tan J, Wang Y, Zhang A Antioxidants (Basel). 2024; 13(6).

PMID: 38929076 PMC: 11200899. DOI: 10.3390/antiox13060638.


Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer's disease and vascular dementia.

Chua X, Torta F, Chong J, Venketasubramanian N, Hilal S, Wenk M Alzheimers Res Ther. 2023; 15(1):214.

PMID: 38087395 PMC: 10714620. DOI: 10.1186/s13195-023-01359-7.


Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).

de la Monte S J Alzheimers Dis. 2023; 95(4):1301-1337.

PMID: 37718817 PMC: 10896181. DOI: 10.3233/JAD-230555.


Decreased DHA-containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ , phosphorylated α-synuclein, and synaptopathology.

Chong J, Chai Y, Xing H, Herr D, Wenk M, Francis P Brain Pathol. 2023; 33(6):e13190.

PMID: 37463072 PMC: 10580008. DOI: 10.1111/bpa.13190.


Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer's Disease.

Obis E, Sol J, Andres-Benito P, Martin-Gari M, Mota-Martorell N, Galo-Licona J Aging Dis. 2023; 14(5):1887-1916.

PMID: 37196109 PMC: 10529741. DOI: 10.14336/AD.2023.0217.


References
1.
Wallin A, Gottfries C, Karlsson I, Svennerholm L . Decreased myelin lipids in Alzheimer's disease and vascular dementia. Acta Neurol Scand. 1989; 80(4):319-23. DOI: 10.1111/j.1600-0404.1989.tb03886.x. View

2.
OBrien J, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L . Vascular cognitive impairment. Lancet Neurol. 2003; 2(2):89-98. DOI: 10.1016/s1474-4422(03)00305-3. View

3.
Tomimoto H . Subcortical vascular dementia. Neurosci Res. 2011; 71(3):193-9. DOI: 10.1016/j.neures.2011.07.1820. View

4.
Pettegrew J, Panchalingam K, Hamilton R, McClure R . Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem Res. 2001; 26(7):771-82. DOI: 10.1023/a:1011603916962. View

5.
Roman G, Erkinjuntti T, Wallin A, Pantoni L, Chui H . Subcortical ischaemic vascular dementia. Lancet Neurol. 2003; 1(7):426-36. DOI: 10.1016/s1474-4422(02)00190-4. View